WuXi PharmaTech (NYSE: WX) Holds Its Second Life Science and Chemistry Awards Ceremony in Beijing

Thursday, December 18, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

SHANGHAI, China, Dec. 18 WuXi PharmaTech (NYSE: WX),a leading pharmaceutical, biotechnology, medical device research anddevelopment outsourcing company with operations in China and the United States,announced today that the company successfully held its second Life Science andChemistry Awards Ceremony on December 7, 2008 at the Great Hall of the People,Beijing, China.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

With the whole process starting in July, the second "WuXi PharmaTech LifeScience and Chemistry Award" set the scope of the selection as preclinicalpharmacology and toxicology. This year's selection panel was comprised ofeleven scholars with industry expertise. Dr. Sang Guowei, Vice Chairman of theStanding Committee of the National People's Congress, served as Chairman ofthe selection panel. Other panel members included Dr. Wang Li, Professor ofSichuan University and Director of Chendu Traditional Chinese Medicine SafetyEvaluation Center, Dr Li Bo, Director of the National Center for SafetyEvaluation of Drugs, Dr. Li Ge, Chairman and Chief Executive Officer of WuXiPharmaTech, Dr. Zhang Yongxiang, Vice Director of the Science and TechnologyDepartment of Academy of Military Medical Sciences and Researcher of ResearchInstitute of Drugs and Toxicants, Dr. Chen Kaixian, President of the ShanghaiUniversity of Traditional Chinese Medicine and Academician of Chinese Academyof Sciences, Dr. Chen Shuhui, Chief Scientific Officer of WuXi PharmaTech, Dr.Lin Guoqiang, Professor of the Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences and Academician of Chinese Academy of Sciences, Dr.Zhou Honghao, Professor of Central South University and Academician of ChineseAcademy of Engineering, Dr. Yuan Bojun, QA Director and Professor of New DrugSafety Evaluation of Second Military Medical University, and Dr. Liao Mingyang,Director of National Beijing Center of New Drug Safety Evaluation Research ofResearch Institute of Drugs and Toxicants of Academy of Military MedicalSciences.

Twelve winners were selected through rigorous, objective and transparentevaluation. Dr. Wang Guangji, Vice President of China PharmaceuticalUniversity, won the Special Prize. The First Prize winners are Dr. Ren Jin,Director of Safety Evaluation Center of Shanghai Institute of Materia Medica,Chinese Academy of Sciences and Dr. Li Chuan, Researcher of Shanghai Instituteof Materia Medica Chinese Academy of Sciences. The Second Prize winners are Dr.Ma Jin, Director of the National Shanghai Center for New Drug SafetyEvaluation and Research, Dr. Zhu Yichun, Professor of Fudan University, Dr. LuGuocai, Director of New Drug Safety Evaluation of Second Military MedicalUniversity, and Dr. Guo Qinglong, Professor of Department of Physiology ofChina Pharmaceutical University. The Third Prize winners are Dr. Wang Quanjun,Vice Group Leader of the General Toxicology Group of the National BeijingCenter for New Drug Safety Evaluation Research of Research Institute of Drugsand Toxicants of Academy of Military Medical Sciences, Dr. Mao Yu, Researcherof New Drug Safety Evaluation of Second Military Medical University, Dr. YangJingyu, Associate Dean for Life Science and Biopharmaceuticals in ShenyangPharmaceutical University, Dr. Jiang Dejian, Vice Researcher of the Departmentof Pharmacology of Pharmaceutical Faculty in Central South University and Dr.Ju Zhenyu, Associate Professor of the Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences.

"I am honored to receive the 'WuXi PharmaTech Life Science and ChemistryAward'. This award recognizes my research work and further spurs me to put myheart and soul into pharmaceutical research and development. WuXi, as aleading pharmaceutical, biotechnology and medical device research anddevelopment outsourcing company, founded this award to support and inspirethose who engage in pharmaceutical research and development and promote ourbasic scientific research and innovation related to life science andchemistry." commented Dr. Wang Guangji, the Special Prize winner, VicePresident of China Pharmaceutical University.

Dr. Sang Guowei, Vice Chairman of the Standing Committee of the NationalPeople's Congress, and Mr. Zhang Huaixi, Vice Chairman of the Tenth ChinesePeople's Political Consultative Conference attended the awards ceremony,presented the awards to the winners, and had a warm talk with them,encouraging them to make more contributions to China's pharmaceutical researchand scientific development.

The second "WuXi PharmaTech Life Science and Chemistry Award" receivedgreat support from the Tianjin Economic-Technological Development Area andSuzhou Wuzhong District.

"We are honored to hold the second 'WuXi PharmaTech Life Science andChemistry Award'. Without a robust talent pool available in China, without thesupport from our society, it is impossible for WuXi to achieve today'sachievements. We hereby want to express our sincere gratitude to all of thosewho support WuXi. We hope this award will continually drive the scientificinnovation and help to transform the drug research and development, thusultimately to improve and save lives." commented Dr. Ge Li, Chairman and ChiefExecutive Officer of WuXi PharmaTech.

About WuXi PharmaTech Life Science and Chemistry Award

The WuXi PharmaTech Life Science and Chemistry Award was approved andendorsed by the National Office of Science and Technology Awards in February,2007, designed to promote China's scientific and technological development.WuXi PharmaTech will reward young professionals of Chinese citizenship whomake an outstanding achievement in the field of chemistry, biology, or otherlife science related disciplines. Each year the scope of the award selectionwill be settled on chemistry, toxicology, biology, pharmacology or one of therelated fields.

WuXi PharmaTech provides one million RMB to fund such an annual awardbeginning in 2007. The Special Prize winners, First Prize winners, SecondPrize winners and Third Prize winners will get a reward of 200,000 RMB,100,000 RMB, 50,000 RMB and 20,000 RMB respectively.

In the first half of the calendar year the award organization settles thescope of the award selection and announces the selection procedure on thecorporate website and in related academic journals. Applications are acceptedthrough both individual submission and recommendations by scholars andprofessors in the related fields. In the second half of the calendar year aselection panel is built to conduct the award selection and the company willhold the awards ceremony at the end of the year.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech providespharmaceutical, biotechnology and medical device companies a broad andintegrated portfolio of laboratory and manufacturing services throughout thedrug and medical device R&D process. WuXi PharmaTech's services are designedto assist its global partners in shortening the cycle and lowering the cost ofdrug and medical device R&D. The operating subsidiaries of WuXi PharmaTech areknown as WuXi AppTec. For more information, please visit:http://www.wuxiapptec.com .For more information, please contact: Sherry Shao WuXi PharmaTech (Cayman) Inc. Tel: +86-21-5046-4002 Email: pr@wuxiapptec.com

SOURCE WuXi PharmaTech (Cayman) Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store